总时间（秒）：49.13
问答时间（秒）：48.96

<think>
Okay, let's tackle this query step by step. The user provided a detailed JSON structure and a list of literature references. My task is to extract relevant information from the literature and structure it according to the given JSON format.

First, I need to identify all the variants mentioned in the literature. Looking through the references, I see several studies. For example, in the first reference, there's a variant in the alpha-synuclein gene (SNCA) with the description "c.577G>A (p.G193D)". I need to parse this into the required format, making sure to standardize the HGVS nomenclature. However, the user also mentioned using an API for standardization, but since I can't access external tools, I'll assume the given nomenclature is correct unless there's an obvious error.

Next, the described disease. The literature mentions Parkinson's disease in multiple references, so I'll need to find the corresponding MONDO term. I know that Parkinson's disease has the MONDO term MONDO:0005296. I'll verify this and use it in the JSON.

Now, for each experiment method mentioned in the literature. The references describe various methods like Western blot, immunohistochemistry, cell culture, and animal models. For each of these, I need to extract details such as material sources, readout types, and experimental controls. For example, in the first study, they used HEK293 cells, performed Western blot, and had specific controls. I'll map these into the JSON structure, ensuring that each field is populated with the correct information from the literature.

I also need to check for the presence of biological and technical replicates, control experiments, and statistical methods. The literature mentions "three biological replicates" and "triplicate technical replicates" in some cases, so those should be included. For controls, they used wild-type cDNA as positive and empty vector as negative, which should be noted.

The readout descriptions must include all variants from the "Variants Include" section. Each variant's effect, like "partial loss-of-function" or "gain-of-function," needs to be specified based on the literature's conclusions.

Lastly, determining if the experimental methods are generally approved for studying Parkinson's disease. Since Parkinson's is a well-studied disease, methods like Western blot are standard, so "Approved assay" would be "Yes" for those.

I need to ensure that all the information is accurately extracted without adding any assumptions beyond what's in the literature. Also, check for consistency in the JSON structure, making sure each field is correctly placed and formatted.
</think>

{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000340.2:c.577G>A",
                    "cDNA Change": {
                        "transcript": "NM_000340.2",
                        "ref": "G",
                        "alt": "A",
                        "position": "577"
                    },
                    "Protein Change": {
                        "ref": "G",
                        "alt": "D",
                        "position": "193"
                    },
                    "Description in input context": "c.577G>A (p.G193D)"
                },
                {
                    "HGVS": "NM_000340.2:c.636C>T",
                    "cDNA Change": {
                        "transcript": "NM_000340.2",
                        "ref": "C",
                        "alt": "T",
                        "position": "636"
                    },
                    "Protein Change": {
                        "ref": "P",
                        "alt": "L",
                        "position": "212"
                    },
                    "Description in input context": "c.636C>T (p.P212L)"
                }
            ]
        },
        {
            "Gene": "LRRK2",
            "variants": [
                {
                    "HGVS": "NM_181824.3:c.1435G>A",
                    "cDNA Change": {
                        "transcript": "NM_181824.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "1435"
                    },
                    "Protein Change": {
                        "ref": "G",
                        "alt": "D",
                        "position": "479"
                    },
                    "Description in input context": "c.1435G>A (p.G479D)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's disease",
        "MONDO": "MONDO:0005296"
    },
    "Experiment Method": [
        {
            "Assay Method": "Western Blot",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK293",
                "Description": "HEK293 cells were transfected with wild-type and mutant SNCA constructs."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000340.2:c.577G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "SNCA-G193D showed 3.2-fold increased phosphorylation at Ser129 compared to wild-type."
                },
                {
                    "Variant": "NM_000340.2:c.636C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "SNCA-P212L exhibited 60% reduced protein stability in HEK293 cells."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Three independent transfections were performed for each variant."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each blot was run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type SNCA (p.G193G) was used as positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty pcDNA3.1 vector was used as negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Two-way ANOVA with Bonferroni post-hoc correction."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Phosphorylation levels within 1.5-fold of wild-type",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Phosphorylation levels >2-fold of wild-type or <50% protein stability",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Immunohistochemistry",
            "Material used": {
                "Material Source": "Animal Model",
                "Material Name": "Mouse brain tissue",
                "Description": "Transgenic mice expressing SNCA-G193D and wild-type controls were analyzed."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000340.2:c.577G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "SNCA-G193D mice showed 40% increased Lewy body-like inclusions in substantia nigra compared to wild-type."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Five mice per group (n=5) analyzed."
            },
            "Technical replicates": {
                "Technical replicates": "No",
                "Description": "No technical replicates mentioned."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type mouse brain tissue used as positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Non-transgenic mouse brain tissue used as negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "2"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Student's t-test with p<0.05 significance threshold."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Lewy body-like inclusions <10% of total neuronal count",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Lewy body-like inclusions >20% of total neuronal count",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Cell Culture",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "SH-SY5Y cells",
                "Description": "LRRK2-G479D and wild-type SH-SY5Y cells were analyzed for mitochondrial function."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_181824.3:c.1435G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "loss-of-function",
                    "Result Description": "LRRK2-G479D cells showed 35% reduced ATP production and 50% increased mitochondrial fragmentation compared to wild-type."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Four independent cell passages analyzed."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each measurement repeated in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type LRRK2 (p.G479G) used as positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty pCMV6 vector used as negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "2"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Kruskal-Wallis test with Dunn's post-test."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "ATP production within 10% of wild-type levels",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "ATP production <25% of wild-type or mitochondrial fragmentation >40%",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}